MedPath

Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

Phase 1
Recruiting
Conditions
Bell Palsy
Interventions
Registration Number
NCT05821075
Lead Sponsor
October 6 University
Brief Summary

Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies.

Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria
  • unilateral acute facial palsy of no identifiable cause
Exclusion Criteria
  • Recurrent facial Bell's palsy
  • Pregnancy
  • Diabetes
  • Epilepsy
  • Severe hypertension,
  • Renal or hepatic disease,
  • Gastric or duodenal ulcer
  • presence of acute otitis media or ipsilateral chronic otitis
  • Recent head injury,
  • psychiatric disease
  • If there is any contraindications for corticosteroids

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CerebrolysinCerebrolysin-
Prednisolone and CerebrolysinCerebrolysin-
PrednisolonePrednisolone-
Prednisolone and CerebrolysinPrednisolone-
Primary Outcome Measures
NameTimeMethod
change in scores of the house Brackman grading system HBat baseline, after 1 week, after 3 week
changes in scores of the Sunnybrook grading system.at baseline, after 1 week, after 3 week
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

October 6 university hospital

🇪🇬

Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath